Portfolio company
MedLea
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This digital health company develops a digital twin platform to support diagnosis and prognosis of cardiorespiratory disorders for personalised medicine patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Elem
This company develops digital twin platforms that simulate human organs and physiology to conduct virtual clinical trials for pharmaceutical and medical device organisations.
inHEART
This company develops cloud-based AI software that creates 3D cardiac digital twins from medical images to assist cardiologists with procedure planning and heart disease treatment.
BPCOmedia
This company develops a remote monitoring platform using artificial intelligence to predict and prevent respiratory exacerbations for patients with chronic obstructive pulmonary disease.
CueZen
This company develops a digital twin platform for health systems and governments to provide personalised interventions for population health management.
Vestalis
This company develops a remote monitoring platform for healthcare professionals to manage respiratory patients and home-treatment care paths using connected medical devices.
Levron
This company develops a cardio-respiratory physiological assist device that synchronises heart rhythm with respiratory dynamics for patients with chronic heart failure.
Cardisio
This company develops non-invasive screening technology using artificial intelligence and vectorcardiography to detect heart diseases for healthcare professionals and clinical practices.
OMNIA-X
This company develops a health intelligence platform that integrates medical, biometric and behavioural data to provide personalised psychophysical health analysis for individuals.
